Embecta Corp.
USD3.31
-0.18 (-5.16%)
CEO
Devdatt Kurdikar
IPO Date
2022-03-22
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$3.46
Prev. Close
$3.49
Day Low
$3.30
Day High
$3.50
52W Low
$2.77
52W High
$15.55
Market Cap
$0.20B
Volume
1.76M
| 10.5 |
| 30 Sept 2023 | FY | 66.9% | 6.3% | -8.6% | 5.8% | -1.99 | 2.12 | 12.2 |
| 30 Sept 2022 | FY | 68.6% | 19.8% | -25.1% | 20.6% | -1.84 | 2.21 | 7.3 |
| 30 Sept 2021 | FY | 68.7% | 35.6% | 69.8% | 52.6% | 0.00 | 1.78 | 6.4 |
| 30 Sept 2020 | FY | 70.3% | 39.4% | 74.8% | 57.9% | 0.01 | 1.72 | 6.3 |
| 30 Sept 2019 | FY | 70.9% | 39.0% | 74.9% | 58.0% | 0.00 | 1.97 | 6.2 |
| 3.9 |
| 30 Sept 2025 | Q4 | 59.1% | 10.0% | -4.1% | 2.4% | -2.20 | 2.41 | 7.8 |
| 30 Jun 2025 | Q3 | 66.0% | 15.4% | -6.8% | 3.9% | -2.24 | 2.47 | 3.1 |
| 31 Mar 2025 | Q2 | 62.4% | 9.1% | -3.2% | 2.1% | -2.11 | 2.48 | 7.9 |
| 31 Dec 2024 | Q1 | 63.7% | -0.3% | 0.1% | -0.1% | -2.05 | 2.24 | -427.4 |
| 30 Sept 2024 | Q4 | 59.9% | 5.1% | -2.0% | 1.1% | -2.18 | 2.03 | 14.2 |
| 30 Jun 2024 | Q3 | 69.0% | 5.4% | -1.9% | 1.2% | -2.16 | 2.11 | 12.2 |
| 31 Mar 2024 | Q2 | 64.1% | 10.1% | -3.8% | 2.4% | -2.15 | 2.29 | 6.5 |
| 31 Dec 2023 | Q1 | 67.0% | 7.2% | -2.5% | 1.7% | -2.06 | 2.20 | 13.5 |